For the Inventor, By the Inventor

Enter assignee name

Laboratoire Theramex

Calculating rank

USPTO Granted Patents = 16

% Expired Patents = 43.8

EPO Patents = 3

Forward Citations = 128

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Jacques Paris (9 out of 11 patents)

Jean Lafay (5 out of 8 patents)

Jean-Louis Thomas (5 out of 7 patents)

4. Jean-Claude Pascal (4 out of 24 patents)

5. Denis Carniato (3 out of 51 patents)

6. Paule Bonnet (3 out of 6 patents)

7. Remi Delansorne (3 out of 4 patents)

8. Thierry Clerc (2 out of 5 patents)

9. Jacqueline Shields (2 out of 4 patents)

10. Igor Duc (2 out of 4 patents)

11. Eric Duranti (2 out of 4 patents)

12. Philippe Maillos (2 out of 4 patents)

13. Michel Lanquetin (2 out of 5 patents)

14. Jean-Luc Moutou (1 out of 2 patents)

15. Florent Mouton (1 out of 2 patents)

16 patents: Sort by Forward Citations

1. 9084796 - Hormonal composition and its use (2015-07-21),

2. 9012667 - Process for introducing a double bond into position 15, 16 of a steroid (2015-04-21),

3. 8476455 - 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them (2013-07-02),

4. 8168619 - Hormonal composition based on a progestational agent and an oestrogen and use thereof (2012-05-01),

5. 7476691 - Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors (2009-01-13),

6. 7030104 - Topical oestroprogestational compositions with a systemic effect (2006-04-18),

7. 6906049 - Contraceptive medicine based on a progestational agent and an oestrogen and preparation method (2005-06-14),

8. 6831073 - Hormonal composition consisting of an oestrogen compound and of a progestational compound (2004-12-14),

9. 6803380 - 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them (2004-10-12),

10. 6737433 - 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them (2004-05-18),

11. 6586402 - LH-RH peptide analogues, their uses and pharmaceutical compositions containing them (2003-07-01),

12. 6191292 - Precursors of the A-ring of vitamin D and method and intermediates for the preparation thereof (2001-02-20),

13. 6180803 - 19-nor-pregnene derivatives and pharmaceuticals containing such derivatives (2001-01-30),

14. 6153587 - Conformationally constrained LH-RH analogues, their uses and (2000-11-28),

15. 5891867 - Hormonal medicaments and their use for the correction of oestrogenic (1999-04-06),

Company Overview

Laboratoire Theramex is a pharmaceutical company based in Monaco, specializing in the development and commercialization of innovative healthcare solutions. The organization focuses on women's health, providing a range of products that address various medical needs. With a commitment to research and development, Theramex aims to enhance the quality of life for women through effective therapies and treatments. Its operations extend across multiple regions, ensuring a global impact in the healthcare sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

16 Patents

#2 in

#2 in Monaco

#37,952 in the World

Laboratoire Theramex

Forward Citations = 128

30 inventors:

Jacques Paris (9 out of 11 patents)

Jean Lafay (5 out of 8 patents)

Jean-Louis Thomas (5 out of 7 patents)

4. Jean-Claude Pascal (4 out of 24 patents)

5. Denis Carniato (3 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Laboratoire Theramex. Retrieved from https://idiyas.com/company/laboratoire-theramex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…